(thirdQuint)To Assess the Level of Adherence of Subjects Receiving SAIZEN Via Easypod in France.

 Subjects will be enrolled in this observational, multi-center study to assess adherence and treatment outcomes.

 Parents will provide their written agreement to upload their child's data in the study electronic CRF.

 Easypod cent is an electromechanical device that delivers growth hormone and also records injections' date and time.

 Adherence data will be primarily derived from injections recorded in the Easypod cent device combined with physician data entry of outcome measures (i.

e.

 height & weight).

 This will allow the establishment of adherence profiles and evaluate the link with subsequent clinical outcomes.

 Since this is an observational study, there will be no study-specific clinical interventions and subjects will be treated according to the clinical and laboratory findings as routinely evaluated by the physician.

 Auxological and laboratory data will be reported prospectively throughout the duration of the study.

 At baseline, available data can be recorded retrospectively from the subjects' medical file and Easypod cent device Data will be collected retrospectively and prospectively.

 This will allow the establishment of adherence profiles and subsequent clinical outcomes.

 Collected data will be also analyzed in a multinational pooled analysis of comparable national studies.

 Primary Objective: cent To assess the level of adherence of subjects receiving Saizen(R) via Easypod cent Secondary Objectives: - To describe the impact of adherence on clinical outcomes for subject receiving Saizen(R) via Easypod cent - To identify adherence subject profiling - To asses the Impact of adherence on insulin-like growth factor-1 (IGF1) ranges/levels.

 To Assess the Level of Adherence of Subjects Receiving SAIZEN Via Easypod in France@highlight

This is a National, Multicentre, Observational Registry to study adherence and long term outcomes of therapy in paediatric subjects using Easypod cent electromechanical device for growth hormone treatment from hospitals in France and to assess the level of adherence of subjects receiving SAIZEN(R) via Easypod cent .

